1. High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers.
- Author
-
Dillner, Joakim, Elfström, K Miriam, Blomqvist, Jonas, Engstrand, Lars, Uhlén, Mathias, Eklund, Carina, Boulund, Fredrik, Lagheden, Camilla, Hamsten, Marica, Nordqvist-Kleppe, Sara, Seifert, Maike, Hellström, Cecilia, Olofsson, Jennie, Andersson, Eni, Falk, August Jernbom, Bergström, Sofia, Hultin, Emilie, Pin, Elisa, Pimenoff, Ville N, and Hassan, Sadaf
- Subjects
MEDICAL personnel ,SARS-CoV-2 ,SICK leave ,CLINICAL trial registries ,COVID-19 - Abstract
Background: Whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity among asymptomatic subjects reflects past or future disease may be difficult to ascertain.Methods: We tested 9449 employees at Karolinska University Hospital, Stockholm, Sweden for SARS-CoV-2 RNA and antibodies, linked the results to sick leave records, and determined associations with past or future sick leave using multinomial logistic regression.Results: Subjects with high amounts of SARS-CoV-2 virus, indicated by polymerase chain reaction (PCR) cycle threshold (Ct) value, had the highest risk for sick leave in the 2 weeks after testing (odds ratio [OR], 11.97; 95% confidence interval [CI], 6.29-22.80) whereas subjects with low amounts of virus had the highest risk for sick leave in the 3 weeks before testing (OR, 6.31; 95% CI, 4.38-9.08). Only 2.5% of employees were SARS-CoV-2 positive while 10.5% were positive by serology and 1.2% were positive in both tests. Serology-positive subjects were not at excess risk for future sick leave (OR, 1.06; 95% CI, .71-1.57).Conclusions: High amounts of SARS-CoV-2 virus, as determined using PCR Ct values, was associated with development of sickness in the next few weeks. Results support the concept that PCR Ct may be informative when testing for SARS-CoV-2. Clinical Trials Registration. NCT04411576. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF